List of Tables
Table 1. Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Hormones
Table 4. Major Manufacturers of Cytokines
Table 5. Major Manufacturers of Fusion Proteins
Table 6. Major Manufacturers of Therapeutic Enzymes
Table 7. Major Manufacturers of Vaccines
Table 8. Major Manufacturers of Blood Factors
Table 9. Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 10. Global Generic Active Pharmaceutical Ingredients Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Generic Active Pharmaceutical Ingredients Sales by Regions (2016-2021) & (K MT)
Table 12. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Regions (2016-2021)
Table 13. Global Generic Active Pharmaceutical Ingredients Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027) & (K MT)
Table 15. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Generic Active Pharmaceutical Ingredients Sales by Manufacturers (2016-2021) (K MT)
Table 19. Global Generic Active Pharmaceutical Ingredients Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Generic Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2020
Table 21. Generic Active Pharmaceutical Ingredients Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
Table 23. Global Generic Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Generic Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Active Pharmaceutical Ingredients as of 2020)
Table 25. Key Manufacturers Generic Active Pharmaceutical Ingredients Price (2016-2021) (USD/MT)
Table 26. Generic Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Generic Active Pharmaceutical Ingredients Product Type
Table 28. Date of International Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Generic Active Pharmaceutical Ingredients Sales by Type (2016-2021) (K MT)
Table 31. Global Generic Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
Table 32. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Generic Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
Table 34. Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 35. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027) & (K MT)
Table 36. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Generic Active Pharmaceutical Ingredients Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 40. Global Generic Active Pharmaceutical Ingredients Sales by Application (2016-2021) (K MT)
Table 41. Global Generic Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
Table 42. Global Generic Active Pharmaceutical Ingredients Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Generic Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
Table 44. Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 45. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027) & (K MT)
Table 46. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 50. China Generic Active Pharmaceutical Ingredients Sales (K MT) of Key Companies (2016-2021)
Table 51. China Generic Active Pharmaceutical Ingredients Sales Share by Company (2016-2021)
Table 52. China Generic Active Pharmaceutical Ingredients Revenue (US$ Million) by Company (2016-2021)
Table 53. China Generic Active Pharmaceutical Ingredients Revenue Share by Company (2016-2021)
Table 54. China Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2016-2021)
Table 55. China Generic Active Pharmaceutical Ingredients Sales Share by Type (2016-2021)
Table 56. China Generic Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. China Generic Active Pharmaceutical Ingredients Price (USD/MT) by Type (2016-2021)
Table 58. China Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2022-2027)
Table 59. China Generic Active Pharmaceutical Ingredients Sales Share by Type (2022-2027)
Table 60. China Generic Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. China Generic Active Pharmaceutical Ingredients Revenue Share by Type (2022-2027)
Table 62. China Generic Active Pharmaceutical Ingredients Price (USD/MT) by Type (2022-2027)
Table 63. China Generic Active Pharmaceutical Ingredients Sales (K MT) by Application (2016-2021)
Table 64. China Generic Active Pharmaceutical Ingredients Sales Share by Application (2016-2021)
Table 65. China Generic Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. China Generic Active Pharmaceutical Ingredients Price (USD/MT) by Application (2016-2021)
Table 67. China Generic Active Pharmaceutical Ingredients Sales (K MT) by Application (2022-2027)
Table 68. China Generic Active Pharmaceutical Ingredients Sales Share by Application (2022-2027)
Table 69. China Generic Active Pharmaceutical Ingredients Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. China Generic Active Pharmaceutical Ingredients Revenue Share by Application (2022-2027)
Table 71. China Generic Active Pharmaceutical Ingredients Price (USD/MT) by Application (2022-2027)
Table 72. North America Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 73. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 74. North America Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (K MT)
Table 77. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 80. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 81. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 82. Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 84. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 85. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 89. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 92. Pfizer, Inc. (U.S.) Corporation Information
Table 93. Pfizer, Inc. (U.S.) Description and Business Overview
Table 94. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 96. Pfizer, Inc. (U.S.) Recent Development
Table 97. Novartis International AG (Switzerland) Corporation Information
Table 98. Novartis International AG (Switzerland) Description and Business Overview
Table 99. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Novartis International AG (Switzerland) Product
Table 101. Novartis International AG (Switzerland) Recent Development
Table 102. Sanofi (France) Corporation Information
Table 103. Sanofi (France) Description and Business Overview
Table 104. Sanofi (France) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Sanofi (France) Product
Table 106. Sanofi (France) Recent Development
Table 107. Boehringer Ingelheim (Germany) Corporation Information
Table 108. Boehringer Ingelheim (Germany) Description and Business Overview
Table 109. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Boehringer Ingelheim (Germany) Product
Table 111. Boehringer Ingelheim (Germany) Recent Development
Table 112. Bristol-Myers Squibb (U.S.) Corporation Information
Table 113. Bristol-Myers Squibb (U.S.) Description and Business Overview
Table 114. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Bristol-Myers Squibb (U.S.) Product
Table 116. Bristol-Myers Squibb (U.S.) Recent Development
Table 117. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 118. Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
Table 119. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Teva Pharmaceutical Industries Ltd. (Israel) Product
Table 121. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 122. Eli Lilly and Company (U.S.) Corporation Information
Table 123. Eli Lilly and Company (U.S.) Description and Business Overview
Table 124. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Eli Lilly and Company (U.S.) Product
Table 126. Eli Lilly and Company (U.S.) Recent Development
Table 127. GlaxoSmithKline plc (U.K.) Corporation Information
Table 128. GlaxoSmithKline plc (U.K.) Description and Business Overview
Table 129. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. GlaxoSmithKline plc (U.K.) Product
Table 131. GlaxoSmithKline plc (U.K.) Recent Development
Table 132. Merck & Co., Inc. (U.S.) Corporation Information
Table 133. Merck & Co., Inc. (U.S.) Description and Business Overview
Table 134. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Merck & Co., Inc. (U.S.) Product
Table 136. Merck & Co., Inc. (U.S.) Recent Development
Table 137. AbbVie Inc. (U.S.) Corporation Information
Table 138. AbbVie Inc. (U.S.) Description and Business Overview
Table 139. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. AbbVie Inc. (U.S.) Product
Table 141. AbbVie Inc. (U.S.) Recent Development
Table 142. Generic Active Pharmaceutical Ingredients Market Trends
Table 143. Generic Active Pharmaceutical Ingredients Market Drivers
Table 144. Generic Active Pharmaceutical Ingredients Market Challenges
Table 145. Generic Active Pharmaceutical Ingredients Market Restraints
Table 146. Generic Active Pharmaceutical Ingredients Customers List
Table 147. Generic Active Pharmaceutical Ingredients Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Hormones Product Picture
Figure 5. Cytokines Product Picture
Figure 6. Fusion Proteins Product Picture
Figure 7. Therapeutic Enzymes Product Picture
Figure 8. Vaccines Product Picture
Figure 9. Blood Factors Product Picture
Figure 10. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2027
Figure 11. Oncology
Figure 12. Diabetes
Figure 13. Cardiovascular Disease
Figure 14. CNS and Neurological Disorders
Figure 15. Endocrinology
Figure 16. Others
Figure 17. Generic Active Pharmaceutical Ingredients Report Years Considered
Figure 18. Global Generic Active Pharmaceutical Ingredients Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Generic Active Pharmaceutical Ingredients Market Size 2016-2027 (US$ Million)
Figure 20. Global Generic Active Pharmaceutical Ingredients Sales 2016-2027 (K MT)
Figure 21. Global Generic Active Pharmaceutical Ingredients Market Size Market Share by Region: 2021 Versus 2027
Figure 22. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Figure 23. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
Figure 24. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Figure 25. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
Figure 26. Global Generic Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2020
Figure 27. The Top 10 and 5 Players Market Share by Generic Active Pharmaceutical Ingredients Revenue in 2020
Figure 28. Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Figure 30. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 31. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
Figure 32. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type in 2020
Figure 33. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Figure 34. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 35. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
Figure 36. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application in 2020
Figure 37. China Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2027 (K MT)
Figure 38. China Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2027 (US$ Million)
Figure 39. China Generic Active Pharmaceutical Ingredients Market Share in Global Market 2016-2027
Figure 40. China 5 and 10 Largest Generic Active Pharmaceutical Ingredients Players Market Share by Revenue in Generic Active Pharmaceutical Ingredients in 2020
Figure 41. China Generic Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
Figure 42. China Generic Active Pharmaceutical Ingredients Revenue Growth Rate by Type in 2016 & 2020
Figure 43. China Generic Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
Figure 44. China Generic Active Pharmaceutical Ingredients Revenue Growth Rate by Application in 2016 & 2020
Figure 45. North America Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (K MT)
Figure 46. North America Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 48. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 49. U.S. Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 50. U.S. Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Canada Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 52. Canada Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Europe Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (K MT)
Figure 54. Europe Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
Figure 55. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 56. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 57. Germany Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 58. Germany Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. France Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 60. France Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. U.K. Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 62. U.K. Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Italy Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 64. Italy Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Russia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 66. Russia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (K MT)
Figure 68. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
Figure 69. Asia Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
Figure 70. Asia Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
Figure 71. China Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 72. China Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Japan Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 74. Japan Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. South Korea Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 76. South Korea Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. India Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 78. India Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Australia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 80. Australia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Taiwan Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 82. Taiwan Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Indonesia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 84. Indonesia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Thailand Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 86. Thailand Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Malaysia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 88. Malaysia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Philippines Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 90. Philippines Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Vietnam Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 92. Vietnam Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Latin America Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (K MT)
Figure 94. Latin America Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 96. Latin America Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 97. Mexico Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 98. Mexico Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Brazil Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 100. Brazil Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Argentina Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 102. Argentina Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Growth Rate 2016-2021 (K MT)
Figure 104. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2021 (US$ Million)
Figure 105. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 106. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 107. Turkey Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 108. Turkey Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Saudi Arabia Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 110. Saudi Arabia Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 111. UAE Generic Active Pharmaceutical Ingredients Sales Growth Rate (2016-2021) (K MT)
Figure 112. UAE Generic Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 113. Generic Active Pharmaceutical Ingredients Value Chain
Figure 114. Channels of Distribution
Figure 115. Distributors Profiles
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
